Unknown PHASE4 INTERVENTIONAL 2-arm NCT02435797

Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction

Effect of Early Administration of Intracoronary Nicorandil Via Thrombus Aspiration Catheter Device During Primary Percutaneous Coronary Intervention for the Patients of Acute ST Segment Elevation Myocardial Infarction

Sponsor: Xuzhou Central Hospital

Conditions Coronary Heart Disease

Interventions Nicorandil normal saline

Updated 7 times since 2017 Last updated: May 5, 2015 Started: Apr 30, 2015 Primary completion: Aug 31, 2015 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Coronary Heart Disease, this trial is ongoing. The trial is conducted by Xuzhou Central Hospital and has accumulated 7 data snapshots since 2015. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jun 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Feb 2017 — Jun 2017 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xuzhou Central Hospital

Data source: Xuzhou Central Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xuzhou, China